Durden, MD, PhD, pediatric researcher at University of California, San Diego School of Medicine and Moores Cancer Center has identified and developed a novel therapeutic target for neuroblastoma, the second most common solid-tumor childhood cancer. The agent, named SF1126, acts by inhibiting the part of the cancer cell engine that promotes tumor angiogenesis and growth. Novel Therapeutic Agent for Pediatric Cancer Developed at UC San Diego in Clinical Trials.

Fostering faculty excellence and a diverse campus community. Fellowships, awards, and grants. Articles, best practices, and other tools.

The University of California, San Diego. Have launched a new center to understand, enhance and enact the gift of human imagination. The mission of the Center is to help society become more effective at harnessing imagination. This pursuit will bring together the inventive power of science and technology, with the critical analysis of the humanities, and the expressive insight of the arts.

Sign up for the NEW Korean Studies Minor this year! Program in Transnational Korean Studies.